381 related articles for article (PubMed ID: 31738991)
1. Autophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function.
Galle-Treger L; Hurrell BP; Lewis G; Howard E; Jahani PS; Banie H; Razani B; Soroosh P; Akbari O
J Allergy Clin Immunol; 2020 Feb; 145(2):502-517.e5. PubMed ID: 31738991
[TBL] [Abstract][Full Text] [Related]
2. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
3. IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism, and ameliorates airway hyperreactivity.
Howard E; Lewis G; Galle-Treger L; Hurrell BP; Helou DG; Shafiei-Jahani P; Painter JD; Muench GA; Soroosh P; Akbari O
J Allergy Clin Immunol; 2021 Apr; 147(4):1281-1295.e5. PubMed ID: 32905799
[TBL] [Abstract][Full Text] [Related]
4. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
[TBL] [Abstract][Full Text] [Related]
5. Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.
Hurrell BP; Howard E; Galle-Treger L; Helou DG; Shafiei-Jahani P; Painter JD; Akbari O
Front Immunol; 2020; 11():542818. PubMed ID: 33193309
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity.
Galle-Treger L; Suzuki Y; Patel N; Sankaranarayanan I; Aron JL; Maazi H; Chen L; Akbari O
Nat Commun; 2016 Oct; 7():13202. PubMed ID: 27752043
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
[TBL] [Abstract][Full Text] [Related]
9. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
10. Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity.
Sakano Y; Sakano K; Hurrell BP; Helou DG; Shafiei-Jahani P; Kazemi MH; Li X; Shen S; Hilser JR; Hartiala JA; Allayee H; Barbers R; Akbari O
J Allergy Clin Immunol; 2024 May; 153(5):1406-1422.e6. PubMed ID: 38244725
[TBL] [Abstract][Full Text] [Related]
11. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.
Drake LY; Iijima K; Kita H
Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma.
Aron JL; Akbari O
Allergy; 2017 Aug; 72(8):1148-1155. PubMed ID: 28160290
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
14. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
15. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.
Maazi H; Patel N; Sankaranarayanan I; Suzuki Y; Rigas D; Soroosh P; Freeman GJ; Sharpe AH; Akbari O
Immunity; 2015 Mar; 42(3):538-51. PubMed ID: 25769613
[TBL] [Abstract][Full Text] [Related]
16. Group 2 Innate Lymphoid Cells Promote an Early Antibody Response to a Respiratory Antigen in Mice.
Drake LY; Iijima K; Bartemes K; Kita H
J Immunol; 2016 Aug; 197(4):1335-42. PubMed ID: 27421480
[TBL] [Abstract][Full Text] [Related]
17. Activated plasmacytoid dendritic cells regulate type 2 innate lymphoid cell-mediated airway hyperreactivity.
Maazi H; Banie H; Aleman Muench GR; Patel N; Wang B; Sankaranarayanan I; Bhargava V; Sato T; Lewis G; Cesaroni M; Karras J; Das A; Soroosh P; Akbari O
J Allergy Clin Immunol; 2018 Mar; 141(3):893-905.e6. PubMed ID: 28579374
[TBL] [Abstract][Full Text] [Related]
18. T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.
Li BWS; de Bruijn MJW; Lukkes M; van Nimwegen M; Bergen IM; KleinJan A; GeurtsvanKessel CH; Andeweg A; Rimmelzwaan GF; Hendriks RW
Eur J Immunol; 2019 Jan; 49(1):144-156. PubMed ID: 29762870
[TBL] [Abstract][Full Text] [Related]
19. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Lo R; Howard E; Hurrell BP; Galle-Treger L; Painter JD; Lewis G; Soroosh P; Sharpe AH; Akbari O
Nat Commun; 2020 Aug; 11(1):3998. PubMed ID: 32778730
[TBL] [Abstract][Full Text] [Related]
20. Bilirubin represents a negative regulator of ILC2 in allergic airway inflammation.
He J; Jiang G; Li X; Xiao Q; Chen Y; Xu H; Liu G; Lei A; Zhou P; Shi K; Yang Q; Zhao M; Yao Z; Zhou J
Mucosal Immunol; 2022 Feb; 15(2):314-326. PubMed ID: 34686839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
